EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells

Judit Hodrea, Minh Ngoc Tran iD, Balazs Besztercei, Timea Medveczki, Attila J Szabo iD, Laszlo Őrfi iD, Illes Kovacs iD, Andrea Fekete

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Judit Hodrea und 7 weiteren Autor:innen. Beteiligte Einrichtung: MTA-SE Lendület "Momentum" Diabetes Research Group, Semmelweis University, 1083 Budapest, Hungary. Hauptthemen laut MEDLINE: Glaucoma, Open-Angle, Glaucoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian Scientific Research Fund, Hungarian Academy of Sciences, the Ministry of Innovation and Technology of Hungary from the National Research, Develop-ment and Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary open-angle glaucoma remains a global issue, lacking a definitive treatment. Increased intraocular pressure (IOP) is considered the primary risk factor of the disease and it can be caused by fibrotic-like changes in the trabecular meshwork (TM) such as increased tissue stiffness and outflow resistance. Previously, we demonstrated that the sigma-1 receptor (S1R) agonist fluvoxamine (FLU) has anti-fibrotic properties in the kidney and lung. In this study, the localization of the S1R in TM cells was determined, and the anti-fibrotic efficacy of FLU was examined in both mouse and human TM cells. Treatment with FLU reduced the F-actin rearrangement, inhibited cell proliferation and migration induced by the platelet-derived growth factor and decreased the levels of fibrotic proteins. The protective role of the S1R in fibrosis was confirmed by a more pronounced increase in alpha smooth muscle actin and F-actin bundle and clump formation in primary mouse S1R knockout TM cells. Furthermore, FLU demonstrated its protective effects by increasing the production of nitric oxide and facilitating the degradation of the extracellular matrix through the elevation of cathepsin K. These findings suggest that the S1R could be a novel target for the development of anti-fibrotic drugs and offer a new therapeutic approach for glaucoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glaucoma, Open-AngleGlaucomaHumansMiceAnimalsTrabecular MeshworkFluvoxamineActinsCells, CulturedFibrosisIntraocular PressureSigma-1 Receptor

Stichwörter der Autor:innen

PDGFfibrosisfluvoxaminesigma-1 receptortrabecular meshwork

Substanzen

FluvoxamineActinsSigma-1 Receptor

Autor:innen und Institutionen

  • MTA-SE Lendület "Momentum" Diabetes Research Group, Semmelweis University, 1083 Budapest, Hungary.
  • Pediatric Center, MTA Center of Excellence, Faculty of Medicine, Semmelweis University, 1083 Budapest, Hungary.
  • Department of Biochemistry, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 72712, Vietnam.
  • Institute of Clinical Experimental Research, Semmelweis University, 1094 Budapest, Hungary.
  • Department of Pharmaceutical Chemistry, Semmelweis University, 1092 Budapest, Hungary.
  • Department of Ophthalmology, Semmelweis University, 1085 Budapest, Hungary.

ORCID-Profile: Minh Ngoc Tran, Attila J Szabo, Laszlo Őrfi, Illes Kovacs

Förderung

  • Hungarian Scientific Research Fund
  • Hungarian Academy of Sciences
  • the Ministry of Innovation and Technology of Hungary from the National Research, Develop-ment and Innovation Fund
  • National Research, Development and Innovation Office
  • Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund

Zitieren

APA

Hodrea, J., Tran, M. N., Besztercei, B., Medveczki, T., Szabo, A. J., Őrfi, L., Kovacs, I., & Fekete, A. (2023). Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411646

Vancouver

Hodrea J, Tran MN, Besztercei B, Medveczki T, Szabo AJ, Őrfi L, et al. Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411646

BibTeX
@article{Hodrea2023,
  author = {Hodrea, Judit and Tran, Minh Ngoc and Besztercei, Balazs and Medveczki, Timea and Szabo, Attila J and Őrfi, Laszlo and Kovacs, Illes and Fekete, Andrea},
  title = {Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411646}
}
Kostenlos starten →